In DLBCL, the expression of LAG3 is the highest, and is associated with the expression of PD-L1 and tumor mutation burden, and the double block of LAG3 and TIM3 restores the function of anti-DLBCL T cells. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.